Navigation Links
Thinking with the spinal cord?

Two scientists from the University of Copenhagen have demonstrated that the spinal cord use network mechanisms similar to those used in the brain. The discovery is featured in the current issue of Science.

The research group behind the surprising results consists of Professor Jørn Hounsgaard and Post.doc Rune W. Berg from the University of Copenhagen, and Assistant Professor and PhD Aidas Alaburda from the University of Vilnius. The group has shown that spinal neurons, during network activity underlying movements, show the similar irregular firing patterns as seen in the cerebral cortex.

New approach

"Our findings contradict conventional wisdom about spinal cord functions," says Rune W. Berg from Department of Neuroscience and Pharmacology at the Faculty of Health Sciences.

Until now, the general belief was that the spinal networks functioned mechanically and completely without random impulses. The new discovery enables researchers to use the theory on cortical networks to explore how spinal cords generate movements.

Still puzzled by movement

How humans are able to move at all remains a puzzle. Our muscles are controlled by thousands of nerve cells in the spinal cord. This entire, complex system must work as a whole in order to successfully create a single motion. The new research shows that even if we repeat a certain motion with high accuracy, the involved nerve cells never repeat their activity patterns. This particular observation reflects the organisation of the nerve cells of the cerebral cortex.


'"/>

Source:University of Copenhagen


Page: 1

Related biology news :

1. Thinking the pain away? Study shows the brains painkillers may cause placebo effect
2. Stem cell treatment improves mobility after spinal cord injury
3. Combination therapy leads to partial recovery from spinal cord injury in rats
4. Purdue scientists may have found key to halting spinal cord damage
5. Researchers find molecule that inhibits regrowth of spinal nerve cells
6. Gradient guides nerve growth down spinal cord
7. One small step means giant leap for spinal cord research
8. New study identifies key gene in development of connections between brain and spinal cord
9. Protein fingerprint in spinal fluid could spot Alzheimers disease
10. Elderly spinal cord injuries increase five-fold in 30 years, Jefferson neurosurgeons find
11. Fast and slow -- How the spinal cord controls the speed of movement
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Thinking with the spinal cord

(Date:5/16/2013)... 2013 Reportlinker.com announces that a ... its catalogue: Global Biometric ... http://www.reportlinker.com/p01181929/Global-Biometric-Systems-Market-Forecast--Opportunities-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Security_Systems Lack ... such as photographs, passwords and PIN codes ... in last few years. Security threats such ...
(Date:5/15/2013)... moderating gout risk, new research reveals that vitamin C, ... (urate) levels to a clinically significant degree in patients ... combination with allopurinol, appears to have a weak effect ... to the results published in the American College of ... , Gout is an inflammatory arthritis that causes excruciating ...
(Date:5/15/2013)... clinical trial to date to examine the efficacy of ... other than breast and ovarian cancer, the oral drug ... and prostate cancers. Results of the study, led by ... University of Pennsylvania and Sheba Medical Center in Tel ... of Clinical Oncology,s annual meeting in Chicago in early ...
Breaking Biology News(10 mins):Global Biometric Systems Market Forecast & Opportunities, 2018 2Global Biometric Systems Market Forecast & Opportunities, 2018 3Global Biometric Systems Market Forecast & Opportunities, 2018 4Global Biometric Systems Market Forecast & Opportunities, 2018 5Global Biometric Systems Market Forecast & Opportunities, 2018 6Global Biometric Systems Market Forecast & Opportunities, 2018 7Vitamin C does not lower uric acid levels in gout patients 2PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations 2
... Tuesday, Nov. 16, 2010 Tying in with this ... pre-conference workshops will debut at this year,s TERMIS-North America ... Fla. The TERMIS (Tissue Engineering & Regenerative ... the Wake Forest Institute for Regenerative Medicine, and chaired ...
... SAN DIEGO New research indicates that the ... About two percent of the population has a condition called ... are experienced at once. Although this condition is rare, the ... sometimes overlapping ways to help people interpret and understand their ...
... examining the distinct wave patterns formed from complex biochemical ... more effectively identified, says Zhengdong Cheng, associate professor in ... A&M University, who has developed a model that simulates ... which appear in the October issue of the journal ...
Cached Biology News:Regenerative medicine workshops to debut at TERMIS North America Annual Conference 2Hearing colors, seeing sounds: New research explores sensory overlap in the brain 2Research links damaged organs to change in biochemical wave patterns 2
(Date:5/17/2013)... The new Public-Private Partnership (PPP) in Photonics ... recent annual meeting drew praise from community leaders from ... called the action “a huge step forward … a ... innovation.” , The Board of Stakeholders voted to approve ... at its 29 April meeting in Brussels, which was ...
(Date:5/17/2013)... 17, 2013  Yongye International, Inc. (NASDAQ: ... manufacturer, and distributor of crop nutrient products in ... announced that, on May 16, 2013, the special committee ... "Board of Directors") was provided a letter (the "Letter") ... ) Limited ("Abax") to Full Alliance International Limited ...
(Date:5/17/2013)... 2013 The paradigm of ‘one drug, ... that can help predict the adverse and therapeutic effects ... Head of Computational Biology at the Genomics Laboratory, Covance, ... ensure high-quality genomics when used as part of the ... complex data sets to identify key clinical targets even ...
(Date:5/17/2013)... May 17, 2013 Tooth decay is an ... active signs of the disease. The World Health Organization says ... 100% of adults have cavities. What are the long-term effects ... showing a strong connection between the oral bacterial imbalance and ... disease so rampant, yet it is also 100% preventable? Answer: ...
Breaking Biology Technology:SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... Schering-Plough,Corporation (NYSE: SGP ) today announced that ... the Peg-IFN (peginterferon alfa-2b),supplemental Biologics License Application (sBLA) ... the adjuvant treatment of patients with,Stage III melanoma. ... fall of 2007., The Priority Review designation ...
... Inc. (Nasdaq: ALXA ) announced today that ... 10th Annual BIO CEO & Investor,Conference on Monday, ... The presentation will be webcast from the ... presentation via the Web, please go to the,Investor ...
... Increase to Record Highs, BEDFORD, Mass., Jan. 31 ... technologies company specializing in,diagnostics, imaging systems and interventional devices ... its results for the,quarter ended December 29, 2007., ... revenues of $371.4 million. -- Merger with Cytyc ...
Cached Biology Technology:FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 2FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 3FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 4FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 5FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 6Alexza's Corporate Presentation to be Webcast at the 10th Annual BIO CEO & Investor Conference 2Hologic Announces First Quarter Fiscal 2008 Operating Results 2Hologic Announces First Quarter Fiscal 2008 Operating Results 3Hologic Announces First Quarter Fiscal 2008 Operating Results 4Hologic Announces First Quarter Fiscal 2008 Operating Results 5Hologic Announces First Quarter Fiscal 2008 Operating Results 6Hologic Announces First Quarter Fiscal 2008 Operating Results 7Hologic Announces First Quarter Fiscal 2008 Operating Results 8Hologic Announces First Quarter Fiscal 2008 Operating Results 9Hologic Announces First Quarter Fiscal 2008 Operating Results 10Hologic Announces First Quarter Fiscal 2008 Operating Results 11Hologic Announces First Quarter Fiscal 2008 Operating Results 12Hologic Announces First Quarter Fiscal 2008 Operating Results 13Hologic Announces First Quarter Fiscal 2008 Operating Results 14Hologic Announces First Quarter Fiscal 2008 Operating Results 15
...
Sterile detoxified 10% bovine serum albumin (BSA) in Iscoves MDM. This BSA has been selected to support the optimal colony growth of human hematopoietic progenitor cells in methylcellulose-based medi...
... ICP-MS system designed for flexibility and routine ... off-axis ion lens, true hyperbolic quadrupole and ... the widest range of sample types and ... includes as standard Agilents unique ShieldTorch System, ...
... it uses a deep-UV deuterium bulb, which provides ... a shutter (controlled via a TTL signal or ... DH-2000 Deuterium Tungsten Halogen Light Source combines the ... sources in a single optical path. The combined-spectrum ...
Biology Products: